Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Long-Term Debt Issuances (2020 - 2022)

Maravai Lifesciences Holdings has reported Long-Term Debt Issuances over the past 2 years, most recently at $8.5 million for Q1 2022.

  • Quarterly results put Long-Term Debt Issuances at $8.5 million for Q1 2022, changed N/A from a year ago — trailing twelve months through Dec 2022 was $8.5 million (changed N/A YoY), and the annual figure for FY2024 was $953000.0, changed.
  • Long-Term Debt Issuances for Q1 2022 was $8.5 million at Maravai Lifesciences Holdings, down from $594.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for MRVI hit a ceiling of $594.0 million in Q4 2020 and a floor of $8.5 million in Q1 2022.